Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chondrosarcoma × Metformin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 CNS 1

Conditions

Glioblastoma 8 Brain Neoplasms 5 Neoplasms 4 Glioma 3 Medulloblastoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Ketosis 1 Insulin Resistance 1 Gliosarcoma 1 Diabetes Mellitus 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Chondrosarcoma 1 Cholangiocarcinoma 1 Astrocytoma 1

Interventions

Filgrastim 3 enasidenib 2 Ifosfamide 2 Docetaxel 2 Carboplatin 2 ivosidenib 1 etoposide phosphate 1 Topotecan 1 Thiotepa 1 Thalidomide 1 Radiosurgery 1 Quality of Life 1 Peripheral Blood Stem Cell Transplantation 1 Pentetic Acid 1 Patient Reported Outcome Measures 1 Molecular Diagnostic Techniques 1 Minocycline 1 Metformin 1 Immunotherapy 1 Immunologic Techniques 1 Heparin 1 Gemcitabine 1 Gelclair 1 Fentanyl 1 Etoposide 1 Drug Therapy 1 Cyproheptadine 1 Cyclophosphamide 1 Cryosurgery 1 Chloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02496741 2020-01-09

MACIST

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Completed

CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡